Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer's Disease.

CONCLUSION: The use of CSF AD biomarkers in clinical practice improves the certainty of diagnosis and prognosis of patients, especially in patients in the prodromal phase or in patients with atypical presentations. PMID: 31589110 [PubMed - in process]
Source: Current Aging Science - Category: Geriatrics Tags: Curr Aging Sci Source Type: research